|
⚲
|
| Keyboard |
| Barrett Elizabeth A
✚
|
|
|---|---|
| CIK # | 0001764157 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001764157] | |
| 4 | [0001764157] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Allogene Therapeutics Inc | |
| Barrett Elizabeth A | |
| UroGen Pharma Ltd | |
| Sage Therapeutics Inc | |
| Science 37 Holdings Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
UroGen Pharma Ltd URGN
Restricted Stock Units · derivative
|
2026-01-31 | Grant | 153,195 | $0.00 | |
|
Sage Therapeutics Inc SAGE
Stock Option (Right to Buy) · derivative
|
2025-07-31 | Disposed to issuer | 21,500 | ||
|
Sage Therapeutics Inc SAGE
Common Stock
|
2025-07-31 | Tender | 3,000 | ||
|
UroGen Pharma Ltd URGN
Performance Stock Units · derivative
|
2025-07-28 | Grant | 87,615 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Restricted Stock Unit · derivative
|
2025-06-18 | Grant | 95,400 | $0.00 | |
|
Sage Therapeutics Inc SAGE
Stock Option (Right to Buy) · derivative
|
2025-06-11 | Grant | 21,500 | $0.00 | |
|
UroGen Pharma Ltd URGN
Restricted Stock Units · derivative
|
2025-01-31 | Grant | 96,377 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Stock Option (Right to buy) · derivative
|
2024-06-05 | Grant | 191,082 | $0.00 | |
|
UroGen Pharma Ltd URGN
Restricted Stock Units · derivative
|
2024-01-31 | Grant | 87,615 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Stock Option (Right to Buy) · derivative
|
2023-06-13 | Grant | 116,120 | $0.00 | |
|
UroGen Pharma Ltd URGN
Restricted Stock Units · derivative
|
2023-01-31 | Grant | 75,000 | $0.00 | |
|
UroGen Pharma Ltd URGN
Restricted Stock Units · derivative
|
2023-01-31 | Option exercise | 5,000 | $0.00 | |
|
UroGen Pharma Ltd URGN
Restricted Stock Units · derivative
|
2023-01-31 | Option exercise | 13,333 | $0.00 | |
|
UroGen Pharma Ltd URGN
Employee Stock Option (right to buy) · derivative
|
2023-01-31 | Grant | 125,000 | $0.00 | |
|
UroGen Pharma Ltd URGN
Performance Stock Units · derivative
|
2023-01-31 | Grant | 100,000 | $0.00 | |
|
UroGen Pharma Ltd URGN
Ordinary Shares
|
2023-01-31 | Option exercise | 5,000 | ||
|
UroGen Pharma Ltd URGN
Ordinary Shares
|
2023-01-31 | Option exercise | 13,333 | ||
|
Allogene Therapeutics Inc ALLO
Stock Option (Right to Buy) · derivative
|
2022-06-15 | Grant | 71,070 | $0.00 | |
|
UroGen Pharma Ltd URGN
Stock Option (right to buy) · derivative
|
2022-01-31 | Grant | 150,000 | $0.00 | |
|
UroGen Pharma Ltd URGN
Restricted Stock Units · derivative
|
2022-01-31 | Option exercise | 5,000 | $0.00 | |
| showing 20 of 51 most recent transactions | |||||